I am pleased to share my latest article published by Forbes Business Council. The article discusses why artificial intelligence in genomic medicine should not be driven only by hype or technical excitement, but by strong governance, institutional responsibility, ethical safeguards, and careful clinical adoption. Read the full article here: https://www.forbes.com/councils/forbesbusinesscouncil/2026/05/07/ai-in-genomic-medicine-is-advancing-but-institutions-need-governance-not-

I am pleased to share my Scopus-indexed article titled: “AI-driven genomic medicine: A comprehensive review of clinical applications, institutional dynamics, and governance challenges.” The article discusses how artificial intelligence is transforming genomic medicine, precision healthcare, clinical decision-making, and institutional practice. It also highlights why responsible governance, ethics, patient safety, and clinical reliability are essential as healthcare institutio

I am pleased to share my paper titled “Governance Frameworks for AI-Driven Genomic Medicine: From Innovation to Responsible Clinical Adoption.” The paper focuses on how healthcare institutions can develop responsible governance models for AI-driven genomic medicine, balancing innovation with patient safety, ethics, accountability, and clinical reliability. Read the full paper here: .https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6725678 #AI_Governance #Genomic_Medicine #

The history of #international_trade is not only a history of goods, routes, and markets. It is also a history of #trust, #law, #diplomacy, and #leadership. The Otrar incident, which preceded the Mongol invasion of the Khwarazmian Empire in the early thirteenth century, offers a powerful educational case for students of #business, #economics, and #strategic_studies. Otrar was an important trading city on the Syr Darya, and it became closely associated with the opening stages o